Radiation-induced lung injury: Assessment, management, and prevention

ONCOLOGY

Volumn 22, Issue 1, 2008, Pages 37-47

  Ghafoori, Paiman ^a   Marks, Lawrence B ^a   Vujaskovic, Zeljko ^a   Kelsey, Christopher R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYTOKINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; MITOMYCIN; PACLITAXEL; PENTOXIFYLLINE; PREDNISONE; REACTIVE OXYGEN METABOLITE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG PARENCHYMA; LYMPHOMA; MICROENVIRONMENT; OXIDATIVE STRESS; PNEUMONIA; RADIATION DOSE; RADIATION PNEUMONIA; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; WHOLE BODY RADIATION;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; LUNG; LUNG DISEASES; RADIATION INJURIES; RADIOTHERAPY;

EID: 38949148293     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Marks LB: The pulmonary effects of thoracic irradiation. Oncology (Williston Park) 8:89-106, 1994.
2. Bentzen SM: Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 6:702-713, 2006.
3. Mikkelsen RB, Wardman P: Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22:5734-5754, 2003.
4. Fleckenstein K, Zgonjanin L, Chen L, et al: Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys 68:196-204, 2007.
5. Jackson IL, Batinic-Haberle I, Sonveaux P, et al: ROS production and angiogenic regulation by macrophages in response to heat therapy. Int J Hyperthermia 22:263-273, 2006.
6. Novakova-Jiresova A, van Luijk P, van Goor H, et al: Changes in expression of injury after irradiation of increasing volumes in rat lung. Int J Radiat Oncol Biol Phys 67:1510-1518, 2007.
7. Vujaskovic Z, Anscher MS, Feng QF, et al: Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50:851-855, 2001.
8. Miller KL, Shafman TD, Anscher MS, et al: Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 61:64-69, 2005.
9. Speiser BL, Spratling L: Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. Int J Radiat Oncol Biol Phys 25:589-597, 1993.
10. Nag S, Kelly JF, Horton JL, et al: Brachytherapy for carcinoma of the lung. Oncology (Williston Park) 15:371-381, 2001.
11. Wheater's Functional Histology, 3rd ed. London, Churchill Livingstone, 1993.
12. Rubin P, Shapiro DL, Finklestein JN, et al: The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys 6:75-77, 1980.
13. Allavena C, Conroy T, Aletti P, et al: Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br J Cancer 65:908-912, 1992.
14. Bell J, McGivern D, Bullimore J, et al: Diagnostic imaging of post-irradiation changes in the chest. Clin Radiol 39:109-119, 1988.
15. Kelsey CR, Kahn D, Hollis DR, et al: Radiation-induced narrowing of the tracheobronchial tree: An in-depth analysis. Lung Cancer 52:111-116, 2006.
16. Kocak Z, Evans ES, Zhou SM, et al: Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 62:635-638, 2005.
17. Salinas FV, Winterbauer RH: Radiation pneumonitis: A mimic of infectious pneumonitis. Semin Respir Infect 10:143-153, 1995.
18. Marks LB, Fan M, Clough R, et al: Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints. Int J Radiat Biol 76:469-475, 2000.
19. Monson JM, Stark P, Reilly JJ, et al: Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 82:842-850, 1998.
20. Skoczylas JZ, Bentzen SM, Overgaard M, et al: Time course of radiological lung density changes after postmastectomy radiotherapy. Acta Oncol 39:181-187, 2000.
21. Koenig TR, Munden RF, Erasmus JJ, et al: Radiation injury of the lung after three-dimensional conformai radiation therapy. AJR Am J Roentgenol 178:1383-1388, 2002.
22. Theuws JC, Kwa SL, Wagenaar AC, et al: Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 48:33-43, 1998.
23. Kocak Z, Marks LB: Radiation-induced lung injury, in Perez CA, Bradey LW, Halperin EC, et al (eds): Principles and Practice of Radiation Oncology, vol 1, 4th ed. New York, Lippincott Williams & Wilkins, 2005.
24. Theuws JC, Seppenwoolde Y, Kwa SL, et al: Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys 47:1201-1208, 2000.
25. Woel RT, Munley MT, Hollis D, et al: The time course of radiation therapy-induced reductions in regional perfusion: A prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys 52:58-67, 2002.
26. Myers JN, O'Neil KM, Walsh TE, et al: The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation. Chest 128:3261-3268, 2005.
27. Miller KL, Zhou SM, Barrier RC Jr, et al: Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 56:611-615, 2003.
28. Keane TJ, Van Dyk J, Rider WD: Idiopathic interstitial pneumonia following bone marrow transplantation: The relationship with total body irradiation. Int J Radiat Oncol Biol Phys 7:1365-1370, 1981.
29. Fryer CJ, Fitzpatrick PJ, Rider WD, et al: Radiation pneumonitis: Experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 4:931-936, 1978.
30. Rab GT, Ivins JC, Childs DS Jr, et al: Elective whole lung irradiation in the treatment of osteogenic sarcoma. Cancer 38:939-942, 1976.
31. Breur K, Cohen P, Schweisguth O, et al: Irradiation of the lungs as an adjuvant therapy in the treatment of osteosarcoma of the limbs. An EORTC randomized study. Eur J Cancer 14:461-471, 1978.
32. Newton KA, Spittle MF: An analysis of 40 cases treated by total thoracic irradiation. Clin Radiol 20:19-22, 1969.
33. Cosset JM, Baume D, Pico JL, et al: Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: A non-randomized comparative study of 54 patients at the Institut Gustave-Roussy. Radiother Oncol 15:151-160, 1989.
34. Pino y Torres JL, Bross DS, Lam WC, et al: Risk factors in interstitial pneumonitis following allogenic bone marrow transplantation. Int J Radiat Oncol Biol Phys 8:1301-1307, 1982.
35. Shank B, Chu FC, Dinsmore R, et al: Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys 9:1607-1611, 1983.
36. Deeg HJ, Sullivan KM, Buckner CD, et al: Marrow transplantation for acute non-lymphoblastic leukemia in first remission: Toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant 1:151-157, 1986.
37. Girinsky T, Benhamou E, Bourhis JH, et al: Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol 18:981-986, 2000.
38. Rancati T, Ceresoli GL, Gagliardi G, et al: Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67:275-283, 2003.
39. Robnett TJ, Machtay M, Vines EF, et al: Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48:89-94, 2000.
40. Graham MV, Purdy JA, Emami B, et al: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323-329, 1999.
41. Seppenwoolde Y, De Jaeger K, Boersma LJ, et al: Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60:748-758, 2004.
42. Hernando ML, Marks LB, Bentel GC, et al: Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51:650-659, 2001.
43. Kwa SL, Lebesque JV, Theuws JC, et al: Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42:1-9, 1998.
44. Kim TH, Cho KH, Pyo HR, et al: Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformai radiation therapy for lung cancer. Radiology 235:208-215, 2005.
45. Kong FM, Hayman JA, Griffith KA, et al: Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65:1075-1086, 2006.
46. Oetzel D, Schraube P, Hensley F, et al: Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33:455-460, 1995.
47. Yorke ED, Jackson A, Rosenzweig KE, et al: Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54:329-339, 2002.
48. Tsujino K, Hirota S, Endo M, et al: Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55:110-115, 2003.
49. Willner J, Jost A, Baier K, et al: A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179:548-556, 2003.
50. Fan M, Marks LB, Hollis D, et al: Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol 19:543-550, 2001.
51. Hof H, Herfarth KK, Munter M, et al: Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:335-341, 2003.
52. Kyas I, Hof H, Debus J, et al: Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67:768-774, 2007.
53. Hoyer M, Roed H, Hansen AT, et al: Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66:S128-135, 2006.
54. Nagata Y, Takayama K, Matsuo Y, et al: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427-1431, 2005.
55. Timmerman R, Papiez L, McGarry R, et al: Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946-1955, 2003.
56. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006.
57. Xia T, Li H, Sun Q, et al: Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66:117-125, 2006.
58. Yom SS, Liao Z, Liu HH, et al: Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68:94-102, 2007.
59. Rosenzweig K, Gupta V, Jackson A, et al: Intensity-modulated radiation therapy for inoperable stage III non-small-cell lung cancer (abstract 58). Oncology (Williston Park) 20(suppl 5):21, 2006.
60. Stevens C, Forster K, Zhu X, et al: Excellent local control and survival after extrapleural pneumonectomy and IMRT for mesothelioma. Int J Radiat Oncol Biol Phys 63:S103, 2005.
61. Allen AM, Czerminska M, Janne PA, et al: Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65:640-645, 2006.
62. Rice D, Liao Z, Vaporciyan AA, et al: V20 predicts fatal pulmonary toxicity after extrapleural pneumonectomy and intensity modulated radiation therapy (abstract). Int J Radiat Oncol Biol Phys 66:S63, 2006.
63. Sasse AD, Clark LG, Sasse EC, et al: Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis. Int J Radiat Oncol Biol Phys 64:784-791, 2006.
64. Movsas B, Scott C, Langer C, et al: Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. J Clin Oncol 23:2145-2154, 2005.
65. Antonadou D, Coliarakis N, Synodinou M, et al: Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 51:915-922, 2001.
66. Antonadou D, Throuvalas N, Petridis A, et al: Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 57:402-408, 2003.
67. Komaki R, Lee JS, Milas L, et al: Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58:1369-1377, 2004.
68. Leong SS, Tan EH, Fong KW, et al: Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer. J Clin Oncol 21:1767-1774, 2003.
69. Ozturk B, Egehan I, Atavci S, et al: Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: A double-blind randomized trial. Int J Radiat Oncol Biol Phys 58:213-219, 2004.
70. Chen L, Brizel DM, Rabbani ZN, et al: The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats. Int J Radiat Oncol Biol Phys 60:1520-1529, 2004.
71. Meadors M, Floyd J, Perry MC: Pulmonary toxicity of chemotherapy. Semin Oncol 33:98-105, 2006.
72. Einhorn L, Krause M, Hornback N, et al: Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer 37:2414-2416, 1976.
73. Kouroussis C, Mavroudis D, Kakolyris S, et al: High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: Results of a dose-finding study. Lung Cancer 44:363-368, 2004.
74. Hope AJ, Lindsay PE, El Naqa I, et al: Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65:112-124, 2006.
75. Lind PA, Bylund H, Wennberg B, et al: Abnormalities on chest radiographs following radiation therapy for breast cancer. Eur Radiol 10:484-489, 2000.
76. Borst GR, De Jaeger K, Belderbos JS, et al: Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys 62:639-644, 2005.
77. Choi NC, Kanarek DJ: Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 10(suppl 1):S219-S230, 1994.
78. Abratt RP, Willcox PA: The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys 31:915-919, 1995.
79. Fay M, Tan A, Fisher R, et al: Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61:1355-1363, 2005.
80. Wang S, Liao Z, Wei X, et al: Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66:1399-1407, 2006.
81. Marks LB, Yu X, Vujaskovic Z, et al: Radiation-induced lung injury. Semin Radiat Oncol 13:333-345, 2003.
82. Sampath S, Schultheiss TE, Wong J: Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 63:876-884, 2005.
83. Marks LB, Ma J: Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury. Int J Radiat Oncol Biol Phys 69:4-12, 2007.